VAXCYTE INC. - COMMON

Vaxcyte Reports First Quarter 2021 Financial Results and Provides Business Update

11 May 2021 15:10:00 By Nasdaq GlobeNewswire

Vaxcyte Announces Publication of Preclinical Data Supporting the Potential of VAX-24 for the Prevention of Invasive Pneumococcal Disease

10 May 2021 07:30:00 By Nasdaq GlobeNewswire

Vaxcyte to Present at BofA Securities 2021 Health Care Conference

06 May 2021 15:05:02 By Nasdaq GlobeNewswire

Vaxcyte to Present at 20th Annual Needham Virtual Healthcare Conference

05 Apr 2021 15:30:00 By Nasdaq GlobeNewswire

Vaxcyte Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

29 Mar 2021 15:10:00 By Nasdaq GlobeNewswire

Vaxcyte to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021

22 Mar 2021 15:05:00 By Nasdaq GlobeNewswire

Vaxcyte Announces Publication of Preclinical Proof-of-Concept Data Supporting Potential of VAX-A1, a Novel Conjugate Vaccine Designed to Prevent Group A Strep Infections

06 Jan 2021 07:15:00 By Nasdaq GlobeNewswire